Alpelisib - CAS 1217486-61-7
Not Intended for Therapeutic Use. For research use only.
Category:
Inhibitor
Product Name:
Alpelisib
Catalog Number:
1217486-61-7
Synonyms:
BYL-719; BYL719; BYL 719; Alpelisib;
CAS Number:
1217486-61-7
Description:
Alpelisib, also known as BLY719, is an orally bioavailable phosphatidylinositol 3-kinase (PI3K) inhibitor with potential antineoplastic activity. PI3K inhibitor BYL719 specifically inhibits PIK3 in the PI3K/AKT kinase (or protein kinase B) signaling pathway, thereby inhibiting the activation of the PI3K signaling pathway. This may result in inhibition of tumor cell growth and survival in susceptible tumor cell populations. Activation of the PI3K signaling pathway is frequently associated with tumorigenesis. Dysregulated PI3K signaling may contribute to tumor resistance to a variety of antineoplastic agents.
COA:
Inquire
MSDS:
Inquire
Targets:
PI3K
Current Developer:
Novartis.
Chemical Structure
CAS 1217486-61-7 Alpelisib

Related PI3K Products


CAS 1252594-99-2 ETP-46321

ETP-46321
(CAS: 1252594-99-2)

ETP-46321 is a potent and orally bioavailable PI3K α, δ inhibitor with potent biochemical and cellular activity and good pharmacokinetic properties (PK) after o...

CAS 1166227-08-2 A66

A66
(CAS: 1166227-08-2)

Inhibition of p110α alone by A66 treatment is sufficient to block insulin signalling to Akt/PKB in certain cell lines that harbor H1047R mutations in PIK3CA and...

AM-9635
(CAS: 1338483-10-5)

AM-9635 is a selective Phosphatidylinositol-3-kinase delta (PI3Kδ) inhibitor. AM-9635 exhibits good cellular potency (in vitro pAKT IC50 = 4.2 nM ). AM-9635 can...

CAS 1173900-33-8 AZD6482

AZD6482
(CAS: 1173900-33-8)

AZD6482 is a PI3Kβ inhibitor with IC50 of 10 nM, 8-, 87- and 109-fold more selective to PI3Kβ than PI3Kδ, PI3Kα and PI3Kγ. Phase 1.

SAR-405
(CAS: 1523406-39-4)

SAR-405 is a potent and selective inhibitor of phosphoinositide 3-kinase (PI3K) class III isoform Vps34 (IC50= 1.2 nM, Kd= 1.5 nM) without disrupting other PI3K...

CAS 371935-74-9 PI-103

PI-103
(CAS: 371935-74-9)

PI-103 is a potent, cell-permeable, ATP-competitive inhibitor of phosphatidylinositol 3-kinase (PI3K) family members with selectivity toward DNA-PK, PI3K (p110α...

CAS 1201438-56-3 Duvelisib

Duvelisib
(CAS: 1201438-56-3)

Duvelisib, also known as IPI-145 and INK-1197, is an orally bioavailable, highly selective and potent small molecule inhibitor of the delta and gamma isoforms o...

CAS 955977-50-1 PI-3065

PI-3065
(CAS: 955977-50-1)

PI-3065 is a novel potent and selective PI3K p110δ inhibitor with IC50 of 15 nM; exhibits > 100 fold selectivity against p110α, p110β, p110γ, DNA-PK and mTOR.

CAS 1372540-25-4 GSK2636771

GSK2636771
(CAS: 1372540-25-4)

GSK2636771 is an orally bioavailable, substituted benzimidazole inhibitor of the class I phosphoinositide 3-kinase (PI3K) beta isoform with potential antineopla...

CAS 1202777-78-3 BKM120

BKM120
(CAS: 1202777-78-3)

BKM120, also called as buparlisib or NVP-BKM120, activity in a range of preclinical cancermodels, specifically inhbits class I PI3K isoforms, which blocks p110α...

CAS 1404231-34-0 ON 146040

ON 146040
(CAS: 1404231-34-0)

ON 146040 was highly potent in killing hematologic tumor cells with IC50 values in the 150 to 1,000 nM range. In biochemical testing, ON 146040 inhibited PI3K α...

AM-0687
(CAS: 1259522-94-5)

This active molecular is a selective PI3Kδ inhibitor. PI3Kδ is hyperactivated in B-cell malignancies and plays a vital role in the B-cell receptor pathway. AM-0...

AMG319
(CAS: 1608125-21-8)

AMG319 is a potent and selective PI3Kδ inhibitor with IC50 of 18 nM, >47-fold selectivity over other PI3Ks. Phase 2.

CAS 1254036-66-2 GSK2292767

GSK2292767
(CAS: 1254036-66-2)

GSK2292767 is a Phosphatidylinositol 3 kinase delta inhibitor applicated for the treatment of respiratory diseases including asthma and COPD in clinical trials....

CAS 1431697-74-3 CAL-130

CAL-130
(CAS: 1431697-74-3)

CAL-130 is a potent and selective PI3K gamma and delta inhibitor with potential anticancer activity. Constitutive phosphoinositide 3-kinase (PI3K)/Akt activatio...

Duvelisib R enantiomer
(CAS: 1261590-48-0)

The R isomer analogue of Duvelisib which is a high selective PI3K δ/γ inhibitor.

CAS 663619-89-4 TGX-221

TGX-221
(CAS: 663619-89-4)

TGX-221 is a potent, selective, and cell membrane permeable inhibitor of the PI3K p110β catalytic subunit. Recent studies showed that TGX-221 has antiproliferat...

IPI-549
(CAS: 1693758-51-8)

IPI-549, a dihydroisoquinolin derivative, has been found to be a phosphatidylinositol 3 kinase gamma inhibitor, could exhibit antineoplastic activity in solid t...

CAS 593960-11-3 PIK-93

PIK-93
(CAS: 593960-11-3)

PIK-93 is a potent PI3K inhibitor.

CAS 1332075-63-4 PI3k(delta) inhibitor 1

PI3k(delta) inhibitor 1
(CAS: 1332075-63-4)

PI3kδ inhibitor 1 is a potent and selective inhibitor of isoform of PI3Kδ; useful for treating disorders mediated by lipid kinases such as inflammation, immunol...